Characteristic | Participant (n = 77,134) | Men (n = 33,414) | Women (n = 43,720) | P value |
---|---|---|---|---|
Age, years | 56 (52–63) | 56 (52–63) | 56 (52–62) | < 0.001 |
Household incomea, n (%) | < 0.001 | |||
Upper half | 47,747 (61.9) | 22,935 (68.6) | 24,812 (56.8) | |
Lower half | 29,387 (38.1) | 10,479 (31.4) | 18,908 (43.2) | |
Body mass index, kg/m2 | 23.0 (21.2–25.0) | 23.0 (21.2–24.9) | 23.0 (21.2–25.0) | < 0.001 |
Waist circumference, cm | 79 (73–84) | 82 (77–87) | 76 (71–82) | < 0.001 |
Systolic blood pressure, mmHg | 122 (113–133) | 126 (117–135) | 120 (110–130) | < 0.001 |
Diastolic blood pressure, mmHg | 78 (70–82) | 80 (70–85) | 75 (70–80) | < 0.001 |
Triglyceride, mg/dL | 90 (66–124) | 94 (68–133) | 87 (65–117) | < 0.001 |
Total cholesterol, mg/dL | 207 (185–232) | 201 (180–226) | 211 (189–236) | < 0.001 |
HDL cholesterol, mg/dL | 67 (63–74) | 67 (63–74) | 68 (63–75) | < 0.001 |
Alanine aminotransferase, IU/L | 19 (15–26) | 21 (16–29) | 18 (14–24) | < 0.001 |
Aspartate aminotransferase, IU/L | 24 (20–29) | 25 (21–31) | 23 (20–27) | < 0.001 |
γ-glutamyl transpeptidase, IU/L | 22 (15–36) | 32 (21–57) | 17 (13–24) | < 0.001 |
Hypertension, n (%) | 22,386 (29.0) | 10,055 (30.1) | 12,331 (28.2) | < 0.001 |
Diabetes mellitus, n (%) | 5,544 (7.2) | 2,946 (8.8) | 2,598 (5.9) | < 0.001 |
Dyslipidemia, n (%) | 17,064 (22.1) | 5,536 (16.6) | 11,528 (26.4) | < 0.001 |
Cigarette smoking, n (%) | < 0.001 | |||
Never smoker | 54,744 (71.0) | 11,867 (35.5) | 42,877 (98.1) | |
Former smoker | 12,948 (16.8) | 12,631 (37.8) | 317 (0.7) | |
Current smoker | 9,442 (12.2) | 8,916 (26.7) | 526 (1.2) | |
Alcohol consumption, n (%) | < 0.001 | |||
Yes | 31,593 (41.0) | 23,852 (71.4) | 7,741 (17.7) | |
No | 45,541 (59.0) | 9,562 (28.6) | 35,979 (82.3) | |
MVPA, n (%) | < 0.001 | |||
0 time/week | 34,544 (44.8) | 12,345 (36.9) | 22,199 (50.8) | |
1–2 time/week | 12,482 (16.2) | 5,977 (17.9) | 6,505 (14.9) | |
3–4 time/week | 11,174 (14.5) | 5,524 (16.5) | 5,650 (12.9) | |
≥ 5 time/week | 18,934 (24.5) | 9,568 (28.6) | 9,366 (21.4) | |
Charlson comorbidity index, n (%) | < 0.001 | |||
0 | 28,804 (37.3) | 13,799 (41.3) | 15,005 (34.3) | |
1 | 25,965 (33.7) | 10,799 (32.3) | 15,166 (34.7) | |
≥ 2 | 22,365 (29.0) | 8,816 (26.4) | 13,549 (31.0) |